Showing 41–50 of 89 results from Publika

Cataliotti A, Costello-Boerrigter LC, Chen HH, Textor SC, Burnett JC (2012)
Sustained blood pressure-lowering actions of subcutaneous B-type natriuretic peptide (nesiritide) in a patient with uncontrolled hypertension
Mayo Clin Proc, 87 (4), 413-5
PubMed 22469356 DOI 10.1016/j.mayocp.2012.02.003
McKie PM, Cataliotti A, Sangaralingham SJ, Ichiki T, Cannone V, Bailey KR, Redfield MM, Rodeheffer RJ, Burnett JC (2011)
Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: a 9-year follow-up study
Mayo Clin Proc, 86 (12), 1154-60
PubMed 22134933 DOI 10.4065/mcp.2011.0437
Martin FL, McKie PM, Cataliotti A, Sangaralingham SJ, Korinek J, Huntley BK, Oehler EA, Harders GE, Ichiki T, Mangiafico S, Nath KA, Redfield MM, Chen HH, Burnett JC (2011)
Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection
Am J Physiol Regul Integr Comp Physiol, 302 (2), R292-9
PubMed 22071162 DOI 10.1152/ajpregu.00194.2011
Sangaralingham SJ, Heublein DM, Grande JP, Cataliotti A, Rule AD, McKie PM, Martin FL, Burnett JC (2011)
Urinary C-type natriuretic peptide excretion: a potential novel biomarker for renal fibrosis during aging
Am J Physiol Renal Physiol, 301 (5), F943-52
PubMed 21865266 DOI 10.1152/ajprenal.00170.2011
Cannone V, Boerrigter G, Cataliotti A, Costello-Boerrigter LC, Olson TM, McKie PM, Heublein DM, Lahr BD, Bailey KR, Averna M, Redfield MM, Rodeheffer RJ, Burnett JC (2011)
A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community
J Am Coll Cardiol, 58 (6), 629-36
PubMed 21798427 DOI 10.1016/j.jacc.2011.05.011
Tonne JM, Campbell JM, Cataliotti A, Ohmine S, Thatava T, Sakuma T, Macheret F, Huntley BK, Burnett JC, Ikeda Y (2011)
Secretion of glycosylated pro-B-type natriuretic peptide from normal cardiomyocytes
Clin Chem, 57 (6), 864-73
PubMed 21482747 DOI 10.1373/clinchem.2010.157438
Macheret F, Boerrigter G, McKie P, Costello-Boerrigter L, Lahr B, Heublein D, Sandberg S, Ikeda Y, Cataliotti A, Bailey K, Rodeheffer R, Burnett JC (2011)
Pro-B-type natriuretic peptide(1-108) circulates in the general community: plasma determinants and detection of left ventricular dysfunction
J Am Coll Cardiol, 57 (12), 1386-95
PubMed 21414536 DOI 10.1016/j.jacc.2011.01.005
McKie PM, Cataliotti A, Boerrigter G, Chen HH, Sangaralingham SJ, Martin FL, Ichiki T, Burnett JC (2010)
A novel atrial natriuretic peptide based therapeutic in experimental angiotensin II mediated acute hypertension
Hypertension, 56 (6), 1152-9
PubMed 20975033 DOI 10.1161/HYPERTENSIONAHA.110.159210
McKie PM, Cataliotti A, Lahr BD, Martin FL, Redfield MM, Bailey KR, Rodeheffer RJ, Burnett JC (2010)
The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects
J Am Coll Cardiol, 55 (19), 2140-7
PubMed 20447539 DOI 10.1016/j.jacc.2010.01.031
Costello-Boerrigter LC, Boerrigter G, Cataliotti A, Harty GJ, Burnett JC (2010)
Renal and anti-aldosterone actions of vasopressin-2 receptor antagonism and B-type natriuretic peptide in experimental heart failure
Circ Heart Fail, 3 (3), 412-9
PubMed 20176717 DOI 10.1161/CIRCHEARTFAILURE.109.916114